ESMO 2019: Industry Sponsored Satellite Symposia

Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.

Friday 27 September 2019

Understanding the Emerging Role of I-O in GI Cancers

Transforming the Treatment Paradigm in Gastrointestinal Cancers with Immuno Oncology Thumb

Friday, 18:00 - 20:00
View the satellite invitation

Multi-Disciplinary Perspectives on Optimising Patient Outcomes in HER2-Positive eBC

02-Multi-Disciplinary-Perspectives-on-Optimising-Patient-Outcomes-in-HER2-Positive-eBC-ROCHE-thumb

Friday, 18:00 - 20:00
View the satellite invitation

How Immuno-Oncology Has Changed the Melanoma Treatment Landscape

Transforming the Treatment Paradigm in Gastrointestinal Cancers with Immuno Oncology Thumb

Friday, 18:00 - 20:00
View the satellite invitation

Long-Term Experience and Survival: An Overview of I-O Therapy in RCC and Future Research in GU Cancers

Transforming the Treatment Paradigm in Gastrointestinal Cancers with Immuno Oncology Thumb

Friday, 18:00 - 20:00
View the satellite invitation

Cracking the Code of Personalised Healthcare

05-Cracking-the-Code-of-Personalised-Healthcare-ROCHE-thumb

Friday, 18:00 - 20:00
View the satellite invitation

From Trial Evidence to Clinical Practice: Focusing on Patients with mGC and mCRC

Servier

Friday, 18:00 - 20:00
View the satellite invitation

Integrating Precision Medicine: Are We Ready for a Paradigm Shift in Advanced Urothelial Carcinoma?

Is Earlier Better? Translating Clinical Evidence into Individualised Treatment Decisions in Advanced Prostate Cancer Thumbnail

Friday, 18:00 - 20:00
View the satellite invitation

 

Saturday 28 September 2019

DNA Repair Deficiency as an Immunotherapy Target in Gynaecological Cancers

Tesaro Thumb

Saturday, 13:00 - 14:30
View the satellite invitation

Redefining Survival Expectations in Lung Cancer

15-Redefining-Survival-Expectations-in-Lung-Cancer-MSD-thumb

Saturday, 13:00 - 14:30
View the satellite invitation

The Evolving I-O Landscape in NSCLC

Transforming the Treatment Paradigm in Gastrointestinal Cancers with Immuno Oncology Thumb

Saturday, 13:00 - 14:30
View the satellite invitation

The ABCs of CDK 4/6 Inhibitors Who, When, and Why in HR-Positive/HER2-Negative MBC

17-The-ABCs-of-CDK-4-6-Inhibitors-Who-When-and-Why-in-HR-Positive-HER2-Negative-MBC-MEDSCAPE-Thumb

Saturday, 13:00 - 14:30
View the satellite invitation

Are You Passionate about HCC? International Multidisciplinary Team Approaches to HCC Management

18-Are-You-Passionate-about-HCC-International-Multidisciplinary-Team-Approaches-to-HCC-Management-IPSEN-Thumb

Saturday, 13:00 - 14:30
View the satellite invitation

Removing the Brakes on the Immune System: Gearing Up for Tumor-Promoting Inflammation Inhibitors in NSCLC

22-Removing-the-Brakes-on-the-Immune-System-Gearing-Up-for-Tumor-Promoting-Inflammation-Inhibitors-in-NSCLC-NOVARTIS-Thumb

Saturday, 18:30 - 20:00
View the satellite invitation

A New Generation of Treatments for Head and Neck Cancers

15-Redefining-Survival-Expectations-in-Lung-Cancer-MSD-thumb

Saturday, 18:30 - 20:00
View the satellite invitation

Expert Insights in Advanced ALK-Positive NSCLC Addressing Questions Faced by Physicians in Clinical Practice

24-Expert-Insights-in-Advanced-ALK-Positive-NSCLC-Addressing-Questions-Faced-by-Physicians-in-Clinical-Practice-MEDSCAPE-thumb

Saturday, 18:30 - 20:00
View the satellite invitation

HER2-Positive Early Breast Cancer A Personalized Approach to Treatment

25-HER2-Positive-Early-Breast-Cancer-A-Personalized-Approach-to-Treatment-PRIME-thumb

Saturday, 18:30 - 20:00
View the satellite invitation

Real-World Evidence and the Patient Journey: What Does the Future Hold?

26-Real-World-Evidence-and-the-Patient-Journey-What-Does-the-Future-Hold-IPSEN-Thumb

Saturday, 18:30 - 20:00
View the satellite invitation

New Clinical Perspectives Of CTCS in the Era of Precision Medicine

57-New-Clinical-Perspectives-Of-CTCS-in-the-Era-of-Precision-Medicine-MENARINI-Thumb

Saturday, 18:30 - 20:00
View the satellite invitation

 

Sunday 29 September 2019

Expanding the Therapeutic Opportunities in Advanced Prostate Cancer

Is Earlier Better? Translating Clinical Evidence into Individualised Treatment Decisions in Advanced Prostate Cancer Thumbnail

Sunday 13:00 - 14:30
View the satellite invitation

Optimizing Treatment in the Era of Precision Oncology - A Multidisciplinary Approach

30-Optimizing-Treatment-in-the-Era-of-Precision-Oncology-a-Multidisciplinary-Approach-BAYER-Thumb

Sunday, 13:00 - 14:30
View the satellite invitation

GU 2.0 - Patient Care in 2019 and Beyond

31-GU-2.0-Patient-Care-in-2019-and-Beyond-MERCK-PFIZER-Thumb

Sunday, 13:00 - 14:30
View the satellite invitation

Optimising Patient Outcomes and Quality of Life in HR+, HER2– ABC

32-Pfizer

Sunday, 13:00 - 14:30
View the satellite invitation

Making First- and Second-Line Treatment Decisions for Advanced NSCLC

Treating-Lung-Cancer-in-a-Rapidly-Evolving-Landscape-Thumbnail

Sunday, 13:00 - 14:30
View the satellite invitation

Sequencing Strategies in Metastatic Prostate Cancer: Revealing the Cards

37-Sequencing-Strategies-in-Metastatic-Prostate-Cancer-Revealing-the-Cards-SANOFI-Thumb

Sunday, 18:30 - 20:00
View the satellite invitation

Personalised Approaches in Cholangiocarcinoma

38-Personalised-Approaches-in-Cholangiocarcinoma-INCYTE-thumb

Sunday, 18:30 - 20:00
View the satellite invitation

No Maintenance is Not an Option Anymore: Parp Inhibition in Ovarian Cancer

Tesaro Thumb

Sunday, 18:30 - 20:00
View the satellite invitation

Faster Intervention and Better Outcomes in Advanced Pancreatic Cancer Putting it into Practice

41-Faster-Intervention-and-Better-Outcomes-in-Advanced-Pancreatic-Cancer-Putting-it-into-Practice-MEDSCAPE-Thumb

Sunday, 18:30 - 20:00
View the satellite invitation

Precision in Practice: A New Era for Oncology Treatment

58-Precision-in-Practice-A-New-Era-for-Oncology-Treatment-LOXO-Thumb

Sunday, 18:30 - 20:00
View the satellite invitation

 

Monday 30 September 2019

From Triple-Negative to Dx-Positive Breast Cancer: Perspectives and Experience with Cancer Immunotherapy for Patients with Metastatic Triple-Negative Disease

42-Thumb

Monday, 13:00 - 14:30
View the satellite invitation

Right Treatment, Right Time: Improving Outcomes for Patients with Advanced Lung Cancer

43-Right-Treatment-Right-Time-Improvising-Outcomes-for-Patients-with-Advanced-Lung-Cancer-ROCHE-Thumb

Monday, 13:00 - 14:30
View the satellite invitation

Evolving the Treatment Practice of Advanced EGFRm NSCLC

44-Evolving-the-Treatment-Practice-of-Advanced-EGFRm-NSCLC-AstraZeneca-Thumb

Monday, 13:00 - 14:30
View the satellite invitation

EGFR+, ALK+ and ROS1+ NSCLC: More Options, Right Choices

Joining-Together-to-Improve-Overall-Survival-in-Oncogenic-Driven-NSCLC-Thumbnail

Monday, 13:00 - 14:30
View the satellite invitation

Optimising Treatment Outcomes in Patients with Advanced Braf-Mutated Melanoma

47-Optimising-Treatment-Outcomes-in-Patients-with-Advanced-Braf-Mutated-Melanoma-PIERRE-FABRE-Thumb

Monday, 13:00 - 14:30
View the satellite invitation

PARP Inhibitors in Ovarian Cancer Expert Perspectives on Current Clinical Questions

48-PARP-Inhibitors-in-Ovarian-Cancer-Expert-Perspectives-on-Current-Clinical-Questions-CLOVIS-Thumb

Monday, 13:00 - 14:30
View the satellite invitation

Quality Assurance to Optimize HER2+ Breast Cancer Treatment

49-Thumb

Monday, 13:00 - 14:30
View the satellite invitation

Redefining Survival: Latest Advances in the Treatment of Melanoma

15-Redefining-Survival-Expectations-in-Lung-Cancer-MSD-thumb

Monday, 18:30 - 20:00
View the satellite invitation

Defining Biomarker-Guided Immuno-Oncology Treatments

15-Redefining-Survival-Expectations-in-Lung-Cancer-MSD-thumb

Monday, 18:30 - 20:00
View the satellite invitation

Taking the Next Step in Lung Cancer Combination Approaches with Immune Checkpoint Inhibition

54-Taking-the-Next-Step-in-Lung-Cancer-Combination-Approaches-with-Immune-Checkpoint-Inhibition-ASTRAZENECA-Thumb

Monday, 18:30 - 20:00
View the satellite invitation

The Expanding Role of Immune Checkpoint Inhibitors Across Genitourinary Cancers

15-Redefining-Survival-Expectations-in-Lung-Cancer-MSD-thumb

Monday, 18:30 - 20:00
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

View the Complete ESMO 2019 Industry Satellite Symposia Programme